Washington D.C. – In a decisive move signaling a potential shift in federal public health strategy, Health Secretary Robert F. Kennedy Jr. on June 10, 2025, dismissed all 17 members of the Centers for Disease Control and Prevention’s (CDC) key Advisory Committee on Immunization Practices (ACIP).
The ACIP plays a crucial role in establishing recommendations for vaccine use in the United States, guidance that significantly impacts public health policies and insurance coverage nationwide. Secretary Kennedy defended the sweeping action, stating it was necessary “to re-establish public trust in vaccine science.” He further characterized the committee as having acted as “little more than a rubber stamp for any vaccine.”
Reactions and Concerns
The dismissal of the entire panel drew immediate and sharp criticism from leading medical and public health organizations. The American Academy of Pediatrics, the American Medical Association (AMA), and former CDC Director Thomas Frieden were among prominent voices expressing alarm.
Critics warned that the decision could deeply “undermine vaccine confidence” at a time when maintaining high vaccination rates is considered essential for public health. The move was particularly notable for its timing, occurring less than three weeks before the ACIP’s next scheduled meeting on June 25–27, 2025. That meeting was slated to include critical discussions regarding COVID-19 boosters, raising immediate questions about how future vaccine recommendations will be formulated and implemented.
Context Within Proposed HHS Restructuring
The abrupt dismissal of the ACIP panel members comes amid a backdrop of proposed significant restructuring within the Department of Health and Human Services (HHS) under Secretary Kennedy’s leadership. The administration’s 2026 budget plan outlines a major reorganization aimed at consolidating various public health functions.
The proposed plan includes cutting funding for key components of the CDC, specifically targeting its chronic disease and global health centers. These reductions are intended to help fund a new, expansive $20.6 billion agency proposed by the administration: the Administration for a Healthy America (AHA). The AHA is presented as a cornerstone initiative backed by the administration’s “Make America Healthy Again” agenda.
Under this ambitious restructuring proposal, the administration seeks to consolidate a total of 28 agencies currently housed within HHS into a streamlined structure comprising just 15 entities. Furthermore, the plan proposes a substantial reduction in funding for the National Institutes of Health (NIH), with a proposed cut of 40% from its current budget.
Details within the budget proposal indicate that the CDC’s chronic disease center, which previously operated with an annual budget of approximately $1.4 billion, is specifically slated for elimination under this proposed framework.
Implications and Outlook
The twin actions – the immediate dismissal of the ACIP panel and the proposed deep structural and financial changes to the CDC, NIH, and the creation of the AHA – signal a potentially transformative, albeit controversial, period for federal public health institutions. The removal of the expert advisory committee before a scheduled meeting on a timely public health issue like COVID-19 boosters creates uncertainty about the process for developing future vaccine guidance and could impact public acceptance and insurance pathways for new vaccines or recommendations.
The broader budget proposal raises fundamental questions about the future capacity of the CDC to address chronic diseases and global health challenges, as well as the nation’s investment in biomedical research through the NIH. Advocates for the existing structure emphasize the long-established roles and expertise within these agencies.
Secretary Kennedy’s administration contends that the proposed changes, including the creation of the AHA and the ACIP dismissals, are necessary steps to enhance efficiency, restore public trust, and realign health priorities under the “Make America Healthy Again” banner. However, critics argue that dismantling established structures and dismissing expert panels without clear succession plans could destabilize critical public health functions and erode scientific independence.
The full impact of these changes on vaccine policy, disease prevention efforts, and the overall federal public health landscape remains a subject of intense debate and observation as the administration advances its agenda.
